Global Flow Cytometry in Oncology and Immunology Market Research Report 2023

November 2023 | 99 pages | ID: GD73202A62B1EN
QYResearch

Abstracts

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Flow Cytometry in Oncology and Immunology market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

• Agilent
• ABYNTEK BIOPHARMA
• Bio-Rad Laboratories
• Cell Signaling Technology
• Cytek Biosciences
• Danaher Corporation,
• DiaSorin S.p.A (Luminex Corporation),
• Enzi Biochem Inc
• Laboratory Corporation of America Holdings,
• Merck KGaA
• Miltenyi Biotec
• NeoGenomics Laboratories
• OPKO Health
• Sony Group Corporation
• Thermo Fisher Scientific Inc.

Segment by Type

• Products
• Services

Segment by Application

• Immunology
• Oncology
• Solid Tumor

By Region

• North America
• United States
• Canada
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Nordic Countries
• Rest of Europe
• Asia-Pacific
• China
• Japan
• South Korea
• Southeast Asia
• India
• Australia
• Rest of Asia
• Latin America
• Mexico
• Brazil
• Rest of Latin America
• Middle East & Africa
• Turkey
• Saudi Arabia
• UAE
• Rest of MEA

The Flow Cytometry in Oncology and Immunology report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)

Chapter 2: Global market size, regional market size. Market Opportunities and Challenges

Chapter 3: Companies’ Competition Patterns

Chapter 4: Product Type Analysis

Chapter 5: Product Application Analysis

Chapter 6 to 10: Country Level Value Analysis

Chapter 11: Companies’ Outline

Chapter 12: Market Conclusions

Chapter 13: Research Methodology and Data Source

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Market Analysis by Type
  1.2.1 Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
  1.2.2 Products
  1.2.3 Services
1.3 Market by Application
  1.3.1 Global Flow Cytometry in Oncology and Immunology Market Growth by Application: 2018 VS 2022 VS 2029
  1.3.2 Immunology
  1.3.3 Oncology
  1.3.4 Solid Tumor
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered

2 GLOBAL GROWTH TRENDS

2.1 Global Flow Cytometry in Oncology and Immunology Market Perspective (2018-2029)
2.2 Flow Cytometry in Oncology and Immunology Growth Trends by Region
  2.2.1 Global Flow Cytometry in Oncology and Immunology Market Size by Region: 2018 VS 2022 VS 2029
  2.2.2 Flow Cytometry in Oncology and Immunology Historic Market Size by Region (2018-2023)
  2.2.3 Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2024-2029)
2.3 Flow Cytometry in Oncology and Immunology Market Dynamics
  2.3.1 Flow Cytometry in Oncology and Immunology Industry Trends
  2.3.2 Flow Cytometry in Oncology and Immunology Market Drivers
  2.3.3 Flow Cytometry in Oncology and Immunology Market Challenges
  2.3.4 Flow Cytometry in Oncology and Immunology Market Restraints

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue
  3.1.1 Global Top Flow Cytometry in Oncology and Immunology Players by Revenue (2018-2023)
  3.1.2 Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Players (2018-2023)
3.2 Global Flow Cytometry in Oncology and Immunology Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Flow Cytometry in Oncology and Immunology Revenue
3.4 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio
  3.4.1 Global Flow Cytometry in Oncology and Immunology Market Concentration Ratio (CR5 and HHI)
  3.4.2 Global Top 10 and Top 5 Companies by Flow Cytometry in Oncology and Immunology Revenue in 2022
3.5 Flow Cytometry in Oncology and Immunology Key Players Head office and Area Served
3.6 Key Players Flow Cytometry in Oncology and Immunology Product Solution and Service
3.7 Date of Enter into Flow Cytometry in Oncology and Immunology Market
3.8 Mergers & Acquisitions, Expansion Plans

4 FLOW CYTOMETRY IN ONCOLOGY AND IMMUNOLOGY BREAKDOWN DATA BY TYPE

4.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Type (2018-2023)
4.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2024-2029)

5 FLOW CYTOMETRY IN ONCOLOGY AND IMMUNOLOGY BREAKDOWN DATA BY APPLICATION

5.1 Global Flow Cytometry in Oncology and Immunology Historic Market Size by Application (2018-2023)
5.2 Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
6.2 North America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
6.4 North America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
6.5 United States
6.6 Canada

7 EUROPE

7.1 Europe Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
7.2 Europe Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
7.4 Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries

8 ASIA-PACIFIC

8.1 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
8.2 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2018-2023)
8.4 Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia

9 LATIN AMERICA

9.1 Latin America Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
9.2 Latin America Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
9.4 Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size (2018-2029)
10.2 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023)
10.4 Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE

11 KEY PLAYERS PROFILES

11.1 Agilent
  11.1.1 Agilent Company Detail
  11.1.2 Agilent Business Overview
  11.1.3 Agilent Flow Cytometry in Oncology and Immunology Introduction
  11.1.4 Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.1.5 Agilent Recent Development
11.2 ABYNTEK BIOPHARMA
  11.2.1 ABYNTEK BIOPHARMA Company Detail
  11.2.2 ABYNTEK BIOPHARMA Business Overview
  11.2.3 ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Introduction
  11.2.4 ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.2.5 ABYNTEK BIOPHARMA Recent Development
11.3 Bio-Rad Laboratories
  11.3.1 Bio-Rad Laboratories Company Detail
  11.3.2 Bio-Rad Laboratories Business Overview
  11.3.3 Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Introduction
  11.3.4 Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.3.5 Bio-Rad Laboratories Recent Development
11.4 Cell Signaling Technology
  11.4.1 Cell Signaling Technology Company Detail
  11.4.2 Cell Signaling Technology Business Overview
  11.4.3 Cell Signaling Technology Flow Cytometry in Oncology and Immunology Introduction
  11.4.4 Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.4.5 Cell Signaling Technology Recent Development
11.5 Cytek Biosciences
  11.5.1 Cytek Biosciences Company Detail
  11.5.2 Cytek Biosciences Business Overview
  11.5.3 Cytek Biosciences Flow Cytometry in Oncology and Immunology Introduction
  11.5.4 Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.5.5 Cytek Biosciences Recent Development
11.6 Danaher Corporation,
  11.6.1 Danaher Corporation, Company Detail
  11.6.2 Danaher Corporation, Business Overview
  11.6.3 Danaher Corporation, Flow Cytometry in Oncology and Immunology Introduction
  11.6.4 Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.6.5 Danaher Corporation, Recent Development
11.7 DiaSorin S.p.A (Luminex Corporation),
  11.7.1 DiaSorin S.p.A (Luminex Corporation), Company Detail
  11.7.2 DiaSorin S.p.A (Luminex Corporation), Business Overview
  11.7.3 DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Introduction
  11.7.4 DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.7.5 DiaSorin S.p.A (Luminex Corporation), Recent Development
11.8 Enzi Biochem Inc
  11.8.1 Enzi Biochem Inc Company Detail
  11.8.2 Enzi Biochem Inc Business Overview
  11.8.3 Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Introduction
  11.8.4 Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.8.5 Enzi Biochem Inc Recent Development
11.9 Laboratory Corporation of America Holdings,
  11.9.1 Laboratory Corporation of America Holdings, Company Detail
  11.9.2 Laboratory Corporation of America Holdings, Business Overview
  11.9.3 Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Introduction
  11.9.4 Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.9.5 Laboratory Corporation of America Holdings, Recent Development
11.10 Merck KGaA
  11.10.1 Merck KGaA Company Detail
  11.10.2 Merck KGaA Business Overview
  11.10.3 Merck KGaA Flow Cytometry in Oncology and Immunology Introduction
  11.10.4 Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.10.5 Merck KGaA Recent Development
11.11 Miltenyi Biotec
  11.11.1 Miltenyi Biotec Company Detail
  11.11.2 Miltenyi Biotec Business Overview
  11.11.3 Miltenyi Biotec Flow Cytometry in Oncology and Immunology Introduction
  11.11.4 Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.11.5 Miltenyi Biotec Recent Development
11.12 NeoGenomics Laboratories
  11.12.1 NeoGenomics Laboratories Company Detail
  11.12.2 NeoGenomics Laboratories Business Overview
  11.12.3 NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Introduction
  11.12.4 NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.12.5 NeoGenomics Laboratories Recent Development
11.13 OPKO Health
  11.13.1 OPKO Health Company Detail
  11.13.2 OPKO Health Business Overview
  11.13.3 OPKO Health Flow Cytometry in Oncology and Immunology Introduction
  11.13.4 OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.13.5 OPKO Health Recent Development
11.14 Sony Group Corporation
  11.14.1 Sony Group Corporation Company Detail
  11.14.2 Sony Group Corporation Business Overview
  11.14.3 Sony Group Corporation Flow Cytometry in Oncology and Immunology Introduction
  11.14.4 Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.14.5 Sony Group Corporation Recent Development
11.15 Thermo Fisher Scientific Inc.
  11.15.1 Thermo Fisher Scientific Inc. Company Detail
  11.15.2 Thermo Fisher Scientific Inc. Business Overview
  11.15.3 Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Introduction
  11.15.4 Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023)
  11.15.5 Thermo Fisher Scientific Inc. Recent Development

12 ANALYST'S VIEWPOINTS/CONCLUSIONS


13 APPENDIX

13.1 Research Methodology
  13.1.1 Methodology/Research Approach
  13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Global Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Products
Table 3. Key Players of Services
Table 4. Global Flow Cytometry in Oncology and Immunology Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Flow Cytometry in Oncology and Immunology Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Flow Cytometry in Oncology and Immunology Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2018-2023)
Table 8. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Flow Cytometry in Oncology and Immunology Market Share by Region (2024-2029)
Table 10. Flow Cytometry in Oncology and Immunology Market Trends
Table 11. Flow Cytometry in Oncology and Immunology Market Drivers
Table 12. Flow Cytometry in Oncology and Immunology Market Challenges
Table 13. Flow Cytometry in Oncology and Immunology Market Restraints
Table 14. Global Flow Cytometry in Oncology and Immunology Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Flow Cytometry in Oncology and Immunology Market Share by Players (2018-2023)
Table 16. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2022)
Table 17. Ranking of Global Top Flow Cytometry in Oncology and Immunology Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Flow Cytometry in Oncology and Immunology Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Flow Cytometry in Oncology and Immunology Product Solution and Service
Table 21. Date of Enter into Flow Cytometry in Oncology and Immunology Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Flow Cytometry in Oncology and Immunology Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2018-2023)
Table 25. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Type (2024-2029)
Table 27. Global Flow Cytometry in Oncology and Immunology Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2018-2023)
Table 29. Global Flow Cytometry in Oncology and Immunology Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Flow Cytometry in Oncology and Immunology Revenue Market Share by Application (2024-2029)
Table 31. North America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 33. North America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 36. Europe Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2018-2023) & (US$ Million)
Table 39. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 42. Latin America Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2018-2023) & (US$ Million)
Table 45. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size by Country (2024-2029) & (US$ Million)
Table 46. Agilent Company Detail
Table 47. Agilent Business Overview
Table 48. Agilent Flow Cytometry in Oncology and Immunology Product
Table 49. Agilent Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 50. Agilent Recent Development
Table 51. ABYNTEK BIOPHARMA Company Detail
Table 52. ABYNTEK BIOPHARMA Business Overview
Table 53. ABYNTEK BIOPHARMA Flow Cytometry in Oncology and Immunology Product
Table 54. ABYNTEK BIOPHARMA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 55. ABYNTEK BIOPHARMA Recent Development
Table 56. Bio-Rad Laboratories Company Detail
Table 57. Bio-Rad Laboratories Business Overview
Table 58. Bio-Rad Laboratories Flow Cytometry in Oncology and Immunology Product
Table 59. Bio-Rad Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 60. Bio-Rad Laboratories Recent Development
Table 61. Cell Signaling Technology Company Detail
Table 62. Cell Signaling Technology Business Overview
Table 63. Cell Signaling Technology Flow Cytometry in Oncology and Immunology Product
Table 64. Cell Signaling Technology Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 65. Cell Signaling Technology Recent Development
Table 66. Cytek Biosciences Company Detail
Table 67. Cytek Biosciences Business Overview
Table 68. Cytek Biosciences Flow Cytometry in Oncology and Immunology Product
Table 69. Cytek Biosciences Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 70. Cytek Biosciences Recent Development
Table 71. Danaher Corporation, Company Detail
Table 72. Danaher Corporation, Business Overview
Table 73. Danaher Corporation, Flow Cytometry in Oncology and Immunology Product
Table 74. Danaher Corporation, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 75. Danaher Corporation, Recent Development
Table 76. DiaSorin S.p.A (Luminex Corporation), Company Detail
Table 77. DiaSorin S.p.A (Luminex Corporation), Business Overview
Table 78. DiaSorin S.p.A (Luminex Corporation), Flow Cytometry in Oncology and Immunology Product
Table 79. DiaSorin S.p.A (Luminex Corporation), Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 80. DiaSorin S.p.A (Luminex Corporation), Recent Development
Table 81. Enzi Biochem Inc Company Detail
Table 82. Enzi Biochem Inc Business Overview
Table 83. Enzi Biochem Inc Flow Cytometry in Oncology and Immunology Product
Table 84. Enzi Biochem Inc Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 85. Enzi Biochem Inc Recent Development
Table 86. Laboratory Corporation of America Holdings, Company Detail
Table 87. Laboratory Corporation of America Holdings, Business Overview
Table 88. Laboratory Corporation of America Holdings, Flow Cytometry in Oncology and Immunology Product
Table 89. Laboratory Corporation of America Holdings, Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 90. Laboratory Corporation of America Holdings, Recent Development
Table 91. Merck KGaA Company Detail
Table 92. Merck KGaA Business Overview
Table 93. Merck KGaA Flow Cytometry in Oncology and Immunology Product
Table 94. Merck KGaA Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 95. Merck KGaA Recent Development
Table 96. Miltenyi Biotec Company Detail
Table 97. Miltenyi Biotec Business Overview
Table 98. Miltenyi Biotec Flow Cytometry in Oncology and Immunology Product
Table 99. Miltenyi Biotec Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 100. Miltenyi Biotec Recent Development
Table 101. NeoGenomics Laboratories Company Detail
Table 102. NeoGenomics Laboratories Business Overview
Table 103. NeoGenomics Laboratories Flow Cytometry in Oncology and Immunology Product
Table 104. NeoGenomics Laboratories Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 105. NeoGenomics Laboratories Recent Development
Table 106. OPKO Health Company Detail
Table 107. OPKO Health Business Overview
Table 108. OPKO Health Flow Cytometry in Oncology and Immunology Product
Table 109. OPKO Health Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 110. OPKO Health Recent Development
Table 111. Sony Group Corporation Company Detail
Table 112. Sony Group Corporation Business Overview
Table 113. Sony Group Corporation Flow Cytometry in Oncology and Immunology Product
Table 114. Sony Group Corporation Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 115. Sony Group Corporation Recent Development
Table 116. Thermo Fisher Scientific Inc. Company Detail
Table 117. Thermo Fisher Scientific Inc. Business Overview
Table 118. Thermo Fisher Scientific Inc. Flow Cytometry in Oncology and Immunology Product
Table 119. Thermo Fisher Scientific Inc. Revenue in Flow Cytometry in Oncology and Immunology Business (2018-2023) & (US$ Million)
Table 120. Thermo Fisher Scientific Inc. Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Flow Cytometry in Oncology and Immunology Market Size Comparison by Type (2023-2029) & (US$ Million)
Figure 2. Global Flow Cytometry in Oncology and Immunology Market Share by Type: 2022 VS 2029
Figure 3. Products Features
Figure 4. Services Features
Figure 5. Global Flow Cytometry in Oncology and Immunology Market Size Comparison by Application (2023-2029) & (US$ Million)
Figure 6. Global Flow Cytometry in Oncology and Immunology Market Share by Application: 2022 VS 2029
Figure 7. Immunology Case Studies
Figure 8. Oncology Case Studies
Figure 9. Solid Tumor Case Studies
Figure 10. Flow Cytometry in Oncology and Immunology Report Years Considered
Figure 11. Global Flow Cytometry in Oncology and Immunology Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Flow Cytometry in Oncology and Immunology Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Flow Cytometry in Oncology and Immunology Market Share by Region: 2022 VS 2029
Figure 14. Global Flow Cytometry in Oncology and Immunology Market Share by Players in 2022
Figure 15. Global Top Flow Cytometry in Oncology and Immunology Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Flow Cytometry in Oncology and Immunology as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Flow Cytometry in Oncology and Immunology Revenue in 2022
Figure 17. North America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Flow Cytometry in Oncology and Immunology Market Share by Country (2018-2029)
Figure 19. United States Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Canada Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Europe Flow Cytometry in Oncology and Immunology Market Share by Country (2018-2029)
Figure 23. Germany Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. France Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. U.K. Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Italy Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Russia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Nordic Countries Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Asia-Pacific Flow Cytometry in Oncology and Immunology Market Share by Region (2018-2029)
Figure 31. China Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Japan Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. South Korea Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. Southeast Asia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. India Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Australia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 38. Latin America Flow Cytometry in Oncology and Immunology Market Share by Country (2018-2029)
Figure 39. Mexico Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Brazil Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. Middle East & Africa Flow Cytometry in Oncology and Immunology Market Share by Country (2018-2029)
Figure 43. Turkey Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Saudi Arabia Flow Cytometry in Oncology and Immunology Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Agilent Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 46. ABYNTEK BIOPHARMA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 47. Bio-Rad Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 48. Cell Signaling Technology Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 49. Cytek Biosciences Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 50. Danaher Corporation, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 51. DiaSorin S.p.A (Luminex Corporation), Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 52. Enzi Biochem Inc Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 53. Laboratory Corporation of America Holdings, Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 54. Merck KGaA Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 55. Miltenyi Biotec Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 56. NeoGenomics Laboratories Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 57. OPKO Health Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 58. Sony Group Corporation Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 59. Thermo Fisher Scientific Inc. Revenue Growth Rate in Flow Cytometry in Oncology and Immunology Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed